Founder: Brendan Frey (CEO)
Launched: 2014
Headquarters: Toronto
Industry: Biotechnology
Pictured above: Brendan Frey
Deep Genomics medicine being tested in a lab
Deep Genomics uses AI and machine learning to develop lifesaving genetic therapies. Its platform directs geneticists, biologists, chemists, toxicologists, clinicians and drug developers to individuals with rare genetic disorders that would be the best candidates for drug treatment. Top investors include Khosla Ventures and True Ventures.
